Tests:Alpha Fetoprotein, Tumor Marker: Difference between revisions
- Department
- Biochemistry
Tests:Alpha Fetoprotein, Tumor Marker
No edit summary |
No edit summary |
||
| Line 5: | Line 5: | ||
{| class="wikitable" | {| class="wikitable" | ||
! colspan="2" | | ! colspan="2" | | ||
== Overview == | |||
|- | |- | ||
|Department | |Department | ||
|Biochemistry | |Biochemistry | ||
|- | |- | ||
|Test Code | |Test Code | ||
| Line 23: | Line 23: | ||
| | | | ||
|- | |- | ||
! colspan="2" | | ! colspan="2" | | ||
== Specimen Requirements == | |||
|- | |- | ||
|Specimen Type | |Specimen Type | ||
| Line 38: | Line 39: | ||
|0.5 mL <span style="background:#99e6b3"> Li Hep Microtainer </span> | |0.5 mL <span style="background:#99e6b3"> Li Hep Microtainer </span> | ||
|- | |- | ||
! colspan="2" | | ! colspan="2" | | ||
== Aliquot Requirements == | |||
|- | |- | ||
|Sample Type | |Sample Type | ||
| Line 49: | Line 51: | ||
| | | | ||
|- | |- | ||
! colspan="2" | | ! colspan="2" |== Clinical Information == | ||
|- | |- | ||
|Reference Intervals | |Reference Intervals | ||
| Line 65: | Line 67: | ||
|Not required | |Not required | ||
|- | |- | ||
! colspan="2" | | ! colspan="2" | | ||
== Comments == | |||
|- | |- | ||
| colspan="2" | This test is useful as a tumour marker and as a safe and effective supplement to the management of patients undergoing treatment for non-seminomatous testicular cancer and | | colspan="2" | This test is useful as a tumour marker and as a safe and effective supplement to the management of patients undergoing treatment for non-seminomatous testicular cancer and | ||
Revision as of 15:39, 11 March 2025
Overview | |
|---|---|
| Department | Biochemistry |
| Test Code | TAFP |
| Synonyms | Tumour Marker (AFP)
AFP (tumour marker) |
| Turnaround Time | 1 hour to 3 days. |
| Stability – Add test | |
Specimen Requirements | |
| Specimen Type | Serum
Plasma |
| Preferred | 7 mL Plain Red-Top |
| Acceptable | |
| Pediatric Requirements | 0.5 mL Li Hep Microtainer |
Aliquot Requirements | |
| Sample Type | Serum |
| Minimum Volume | 200 µL |
| Aliquot Transportation | |
| == Clinical Information == | |
| Reference Intervals | 0 - 16 µg/L (non-pregnant)
See comment |
| Test Method | Ci8200 analyser, Abbott Reagent. |
| Advanced Notice | Not required |
| Patient Preparation | Not required |
Comments | |
| This test is useful as a tumour marker and as a safe and effective supplement to the management of patients undergoing treatment for non-seminomatous testicular cancer and
certain germ cell cancers, or for patients being monitored after therapy is complete. The test is NOT a screening test for cancer. The test is NOT intended as a screen for neural tube defects. For the serial monitoring of tumours, tumour markers should be tested in the same laboratory. | |